Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NCM – Real Time Price. Currency in USD
9.50
-0.01 (-0.11%)
Market open: Aug 12, 2026, 12:41 PM EDT
9.70
+0.19 (2.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
9.50
-0.01 (-0.11%)
Market open: Aug 12, 2026, 12:41 PM EDT
9.70
+0.19 (2.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $23.4M significantly exceed its total debt $4.3M, ensuring strong financial flexibility
Total current assets $122.8M exceed Total current liabilities $21.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$29.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.71 | 6.05 | 10 | |
| Quick ratio | 5.71 | 5.63 | 10 | |
| Debt to Equity | 0.04 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -641K | -600K | -233K | -248K |
| Operating Income | -35M | -45M | -49M | -85M | -107M |
| Net Income | -42M | -45M | -40M | -79M | -102M |
| EBITDA | -33M | -44M | -48M | -85M | -107M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 39.53 | 5.5 |
| Next quarter | N/A | -1.6 | 1.0 |
| Current year | N/A | 11.69 | 4.0 |
| Next year | 116 | -5.37 | 5.5 |
| Weighted average score | 4.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -52.53 | -47.14 | -15.84 | 3.3 |
| Y/Y | 999 | -98.37 | -25.68 | -78.51 | 3.3 |
| 3y average | 999 | -30.25 | 0.81 | -22.05 | 3.5 |
| 5y average | 563.88 | -4.91 | 16.98 | 1.56 | 5.8 |
| Weighted average score | 4.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |